文献速递肿瘤 PET/CT

神经母细胞瘤治疗前18F-FDG PET的特征与预后价值

Characteristics and prognostic value of pre-treatment 18F-FDG PET in neuroblastoma.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2026-06-05

本研究回顾性纳入2013年1月至2023年9月接受治疗前18F-FDG PET的颅外胚胎性实体瘤患儿,其中41例病理确诊为神经母细胞瘤(NB),PET诊断灵敏度92.7%、特异度95.0%。在37例可分析生存的NB患者中,无进展生存(PFS)与年龄、最大径、SUVmax、TLG、MTV、铁蛋白、NSE及LDH相关,总生存(OS)受年龄、最大径、SUVmax、SUVmean、SUVmax/liver、SUVmean/liver、TLG、MTV、NSE及LDH显著影响。整合最大径、MTV和NSE的列线图具有良好区分度与校准度。

要点

  • 治疗前18F-FDG PET对NB诊断灵敏度92.7%、特异度95.0%。
  • TLG和MTV与NSE、LDH相关,转移与所有血清标志物及PET参数相关。
  • 最大径、MTV和NSE组成的列线图可预测NB患者生存。

核心结论

  • 治疗前18F-FDG PET为NB提供有价值的诊断与预后信息,整合最大径、MTV和NSE的列线图可用于评估病情和预测生存。

研究设计与样本

  • 回顾性分析2013年1月至2023年9月接受治疗前18F-FDG PET的颅外胚胎性实体瘤患儿(NCT06190574),共81例,其中41例病理确诊NB。

主要发现

  • 81例中41例病理确诊NB,18F-FDG PET诊断灵敏度92.7%、特异度95.0%。
  • 转移与所有血清学标志物及PET参数相关,TLG和MTV与NSE和LDH相关。
  • 37例确诊NB患者纳入生存分析,PFS与年龄、最大径、SUVmax、TLG、MTV、铁蛋白、NSE和LDH相关。
  • OS受年龄、最大径、SUVmax、SUVmean、SUVmax/liver、SUVmean/liver、TLG、MTV、NSE和LDH显著影响。
  • 整合最大径、MTV和NSE的预后模型具有良好区分度和校准度。

关键数值与推荐

  • 18F-FDG PET诊断NB的灵敏度为92.7%,特异度为95.0%。
  • PFS相关因素包括年龄、最大径、SUVmax、TLG、MTV、铁蛋白、NSE和LDH。
  • OS相关因素包括年龄、最大径、SUVmax、SUVmean、SUVmax/liver、SUVmean/liver、TLG、MTV、NSE和LDH。
  • 预后列线图纳入最大径、MTV和NSE三个变量。

临床怎么用

  • 治疗前18F-FDG PET可用于NB的诊断鉴别,并借助SUVmax、TLG、MTV等代谢参数辅助预后分层。
  • 可结合最大径、MTV和NSE列线图评估NB患者病情并预测生存结局。

局限性

  • 本研究为单中心回顾性分析,生存分析仅纳入37例确诊NB患者,样本量有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This study aimed to evaluate the imaging features and prognostic value of metabolic parameters derived from pretreatment 18F-FDG PET in pediatric neuroblastoma (NB) patients, and to establish a prognostic prediction model. METHODS: This retrospective analysis included pediatric patients with extracranial embryonic solid tumours, notably NB, who underwent pretreatment 18F-FDG PET between Jan 2013 and Sep 2023 (NCT06190574). PET parameters were recorded, including SUVmax, SUVmean and their liver-normalized ratios (SUVmax/liver, SUVmean/liver), TLG, MTV. The diagnostic value of 18F-FDG PET for distinguishing NB were calculated. Correlations between metabolic parameters and clinical variables (age, gender, NSE, LDH, ferritin, INSS, and INRGSS stages) were analyzed. Survival analysis using the Kaplan-Meier method was performed to identify predictors of PFS and OS. A nomogram incorporating variables selected by univariate COX and LASSO regression was created, with its discrimination and calibration assessed. RESULTS: Among 81 patients, 41 were pathologically confirmed as NB, yielding an 18F-FDG PET sensitivity of 92.7% and specificity of 95.0%. Metastasis was associated with all serological markers and PET parameters. TLG and MTV correlated with NSE and LDH. Of the confirmed NB patients, 37 were eligible for inclusion in survival analysis. PFS was associated with age, maximum diameter, SUVmax, TLG, MTV, ferritin, NSE and LDH. OS was significantly influenced by age, maximum diameter, SUVmax, SUVmean SUVmax/liver, SUVmean/liver, TLG, MTV, NSE, LDH. The prognostic model incorporating maximum diameter, MTV and NSE exhibited favorable discrimination and calibration. CONCLUSION: 18F-FDG PET provides valuable diagnostic and prognostic information for NB. The proposed nomogram integrating maximum diameter, MTV, and NSE serves as a practical tool for assessing patient condition and predicting survival outcomes. TRIAL REGISTRATION: NCT06190574.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Hu W, Qu B, Song Y, et al. Characteristics and prognostic value of pre-treatment 18F-FDG PET in neuroblastoma. Eur J Nucl Med Mol Imaging. 2026. PMID: 42246993. doi:10.1007/s00259-026-07977-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。